Back to results
US 2024/0391948 A1Published application
Novel compound that inhibits tnf-alpha generation and inflammasome activity and preparation method therefor
AssigneesShaperon Inc., Seoul National University R&Db Foundation
InventorSeung Yong SEONG
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel compound and a preparation method therefor. The compound according to the present invention exhibits inhibitory activity against the generation of TNF-α that is an inflammatory cytokine produced by inflammation initiation reaction, and against the generation of IL-1β by inflammasome activation, and thus, can be developed as a therapeutic agent for related inflammatory diseases.
Claims21
A compound represented by formula 1 or a pharmaceutically acceptable salt thereof:
- wherein,
- R1, R2, R3 and R4 are each independently H, halo, C1-5 alkyl, OH, or =O,
- X is substituted or unsubstituted C1-10 alkylene,
- wherein when X is substituted, one or more hydrogen(s) is(are) substituted with linear or branched C1-10 alkyl, halo, OH, SH, NH2, CONH2, or COOH,
- A is C1-10 alkylene, C1-10 heteroalkylene, C1-10 alkenylene, C1-5 alkynylene, C3-8 cycloalkylene, C3-8 heterocycloalkylene, C6-20 arylene, C6-20 heteroarylene, —NR5R6C(O)—, —OR6, —SR6, —NR5R6, —C(O)R6, —C(O)OR6, —C(O)NR5R6, —CH(R5)(R6), —CH(R5)(OR6), —CH(OR5)(OR6), —CH(R5)(SR6), or —CH(SR5)(SR6);
- R5 is H, substituted or unsubstituted C1-10 alkyl, substituted or unsubstituted C1-10 heteroalkyl, substituted or unsubstituted C3-20 cycloalkyl, substituted or unsubstituted C3-20 heterocycloalkyl, substituted or unsubstituted C6-20 aryl, substituted or unsubstituted C6-20 heteroaryl, substituted or unsubstituted C1-10 alkyl-C6-20 cycloalkyl, substituted or unsubstituted C1-10 alkyl-C6-20 heterocycloalkyl, substituted or unsubstituted C1-10 alkyl-C6-20 aryl or substituted or unsubstituted C1-10 alkyl-C6-20 heteroaryl,
- wherein if R5 is substituted, one or more hydrogen(s) is(are) substituted with linear or branched C1-5 alkyl, =O, ORa, SRa, N(Ra)2, or CON(Ra)2, and Ra is H or C1-5 alkyl,
- R6 is a bond, substituted or unsubstituted C1-10 alkylene, substituted or unsubstituted C1-10 heteroalkylene, substituted or unsubstituted C3-20 cycloalkylene, substituted or unsubstituted C3-20 heterocycloalkylene, substituted or unsubstituted C6-20 arylene, or substituted or unsubstituted C6-20 heteroarylene,
- wherein if R6 is substituted, one or more hydrogen(s) is(are) substituted with ═O, linear or branched C1-10 alkyl, C0-10 alkyl-C6-20 aryl, C0-10 alkyl-OH, C0-10 alkyl-NH2, C0-10 alkyl-SH, or C0-10 alkyl-CONH2;
- or R5 and R6 together form C3-20 cycloalkylene, C3-20 heterocycloalkylene, C6-20 arylene or C6-20 heteroarylene;
- Y combines directly with A or with R6, and is H, —(CH2)nCH3, —(CH2)nCOOH, —(CH2)nOH—(CH2)nSO3H, —(CH2)nOSO3H, —(CH2)nPO3H2, —(CH2)nOPO3H2, —(CH2)nSO3NH2, —(CH2)nCONH2, or —(CH2)nC(O)SO3H,
- wherein n is an integer from 0 to 10.
9 more elements
-10. (canceled)
(canceled)
(canceled)
-18. (canceled)
-22. (canceled)
(canceled)
Dependencies are inferred from the claim text.